e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Phenotyping and monitoring of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Associations between BODE index and systemic inflammatory biomarkers in COPD
E. Gaki, K. Kontogianni, A. I. Papaioannou, P. Bakakos, K. I. Gourgoulianis, K. Kostikas, M. Alchanatis, S. Papiris, S. Loukides (Athens, Larisa, Greece)
Source:
Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Session:
Phenotyping and monitoring of airway diseases
Session type:
Poster Discussion
Number:
3515
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Gaki, K. Kontogianni, A. I. Papaioannou, P. Bakakos, K. I. Gourgoulianis, K. Kostikas, M. Alchanatis, S. Papiris, S. Loukides (Athens, Larisa, Greece). Associations between BODE index and systemic inflammatory biomarkers in COPD. Eur Respir J 2011; 38: Suppl. 55, 3515
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Relationship between inflammatory mediators in induced sputum and BODE-index in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007
Can we assess COPD comorbidities by BODE index?
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Functional tests and relation to BODE index in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Assessment of functional status
Year: 2009
Relationship between quality of life and BODE index of stable ex-smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Relationship between BODE index score, respiratory and peripheral muscle strength in chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020
Clinical and inflammatory factors associated with body mass index in COPD patients
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Correlation of BODE index with extrapulmonary comorbidities of COPD patients
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Pulmonary rehabilitation effects on BODE index in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 70s
Year: 2006
Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
The BODE index and other composite variables in COPD
Source: Annual Congress 2013 –Composite variables in COPD and update of prevalence worldwide
Year: 2013
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
What is the best predictor of mortality in chronic obstructive pulmonary disease? (BODE index and CPET)
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Biomarkers in COPD patients: Relationship with severity indices
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005
Fatigue in COPD: association with functional status and hospitalisations
Source: Eur Respir J 2013; 41: 565-570
Year: 2013
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept